Clinical Trial Update: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) [Phase 2]

View source ↗

Summary

A Phase 2b trial evaluating the safety and efficacy of TIN816 in sepsis-associated acute kidney injury, with recruitment status listed as active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury Due to Sepsis

Drugs mentioned

• TIN816

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Kidney Injury Due to Sepsis | Phase 2 | Status: ACTIVE_NOT_RECRUITING